Cann American Corp. (CNNA) Stock
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Cann American Corp.
Cann American Corp. is an early-stage enterprise dedicated to developing specialized Cannabis sativa varieties designed for animal consumption. The company's strategic focus is on markets within various European Union countries. Established in 2004 and headquartered in Cloverdale, California, Cann American Corp. previously operated as Canamed4Pets, Inc. before officially rebranding in December 2019.
Cann American Corp. is headquartered in US.
Cann American Corp. (CNNA) stock trades at $0.01 with a market capitalization of $4.80M. The stock is valued at a price-to-earnings (P/E) ratio of 0.53, price-to-book of -0.72, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades at its 52-week high.
On profitability, Cann American Corp. generates a return on equity (ROE) of -80.82%, return on capital employed of 5.16%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.cnnacorp.com